What’s New in Acne Management: What We Have Learned from Increased Understanding of Acne Pathophysiology

Featured Article

What's New in Acne Management:

What We Have Learned From Increased Understanding of Acne Pathophysiology

Join Drs. Leon H. Kircik, Linda Stein Gold, and Jonathan S. Weiss as they discuss the medical interventions generally targeting one or more of the key factors contributing to the development of acne lesions: follicular hyperproliferation and abnormal desquamation (topical and oral retinoids, azelaic acid, salicylic acid, hormonal therapy), increase sebum production (oral isotretinoin, hormonal therapy), C. acnes proliferation (benzoyl peroxide, topical and oral antibiotics, azelaic acid) and inflammation (oral isotretinoin, oral tetracyclines, topical retinoids, azelaic acid).

Acne pathogenesis is multifactorial and not clearly understood; a key factor includes genetics and may result as in interplay of release of inflammatory mediators into the skin, follicular hyperkeratinization with subsequent plugging of the follicle, Cutibacterium acne (C. acnes), formerly Propionibacterium acnes or P. acnes, follicular colonization and excess sebum production.

C. acnes has been shown to mediate inflammatory processes at the site of the sebaceous follicle contributing to the formation of free radical species and generating pro-inflammatory cytokines. Excess sebum production and C. acnes colonization lead to the formation of microcomedones leading to the development of open or closed comedones, inflammatory papules, pustules and cysts characteristic of acne.

Acne severity and grade (comedonal, papulopustular, mixed, nodular), skin type, presence of acne scarring and postinflammatory hyperpigmentation, menstrual cycle history (in women), skin current skin care regimen are factors influencing treatment with classes of topical agents include: comedolytic (anticomedogenic), antimicrobial, antibiotic and antiinflammatory; each impact on the four main pathogenic features of acne.

FACULTY

Leon H. Kircik, MD
Clinical Professor of Dermatology
Indiana University School of Medicine
Mount Sinai Medical Center, New York, NY
Physicians Skin Care, PLLC
Louisville, KY

Linda Stein Gold, MD
Director, Dermatology Clinical Research
Henry Ford Health System
Detroit, Michigan

Jonathan S. Weiss, MD
Adjunct Assistant Clinical Professor of Dermatology
Emory University School of Medicine
Atlanta, GA
President & Co-Managing Partner
Georgia Dermatology Partners
(Formerly, Gwinnett Dermatology, PC)

Watch Now

Injectable NASHA Gel Skinbooster for Facial Skin Aging in Premenopausal and Postmenopausal Women With Estrogen Deficiency-Associated Not Receiving Hormone Therapy: A Case Series

Mikaela Sonis | Aesthetics, Featured Articles, Latest News, Women | No Comments

Addressing Estrogen Deficiency Skin Aging: A Non-Hormonal Approach Here is an insightful new study featured in the JDD! Intrinsic skin aging associated with estrogen deficiency presents a distinct therapeutic challenge…

Off-Label Uses of Nemolizumab: A Narrative Review

Mikaela Sonis | Atopic Dermatitis, Featured Articles, Latest News | No Comments

Beyond AD and PN: Expanding Horizons for Interleukin-31 Blockade in Treatment-Refractory Pruritus Have you read this article from the JDD? Interleukin-31 receptor alpha targeting has established its place in our…

Skincare Mythbusters: The Real Science Behind Benzoyl Peroxide and Sunless Tanners

Mikaela Sonis | Education, Featured Articles, Latest News, Medical Derm | No Comments

Unpacking clinical data on ingredient safety to separate viral fears from evidence-based facts Some of the most read topics in the JDD archive center on ingredient safety, and we want…

Tags:

Featured Article